NCT03492554View on ClinicalTrials.gov

Electrocardiogram Clinical Validation Study

NACompletedINTERVENTIONAL
Enrollment

602

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

May 14, 2018

Study Completion Date

May 14, 2018

Conditions
Atrial Fibrillation
Interventions
OTHER

1-Lead ECG

All participants will record three single-lead ECGs

DEVICE

12-Lead ECG

All participants will simultaneously record three 12-lead ECGs

Trial Locations (5)

32162

BioClinica- The Villages, The Villages

32806

BioClinicia- Orlando, Orlando

33143

QPS, Miami

55102

Health East, Saint Paul

66211

IQVIA, Overland Park

Sponsors

Lead Sponsor

Apple Inc.
All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Apple Inc.

INDUSTRY